MassaPCocciaGet al
PRESS RELEASE PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in 2026 Companies confirm that markers of weight loss and glycemic control are distinct in preliminary study, with multiple mechanisms identified that provide opportunities to guide indication extension OXFORD, UK and PORTLAND, ME 15 April 2026 Ovation.io, a leading human omics and clinical data company, and PrecisionLife, a precision medicine company transforming how complex chronic diseases are understood and managed, today announced that they have reached agreement to commercialize the outputs of PrecisionLifes analysis of Ovations high quality GLP-1 receptor agonist dataset
Kaplan , MD, PhD, FTOS The Obesity Society President 2020 Learn more Donna H
Does your body naturally produce GLP-1
Reference: Cheng CY, Lo SC, Huang CN, Yang YS, Wang YH, Kornelius E
Our terms and conditions clearly state that referral codes must not be shared publicly, including on social media or online forums